Clinical Trial Update: Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating total neoadjuvant therapy for microsatellite-stable locally advanced low rectal cancer using short-course radiotherapy with intracavita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• OXALIPLATIN (Oxaliplatin)
• Pucotenlimab
• Trifluridine/Tipiracil (TAS-102) (trifluridine/tipiracil)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Rectal Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING